New cardiovascular risk guidelines in the U.S. are shifting how doctors classify patient health, moving away from race-based formulas toward more personalized metrics. Research published in JAMA, led by Allison Peng, MD, of the Johns Hopkins University School of Medicine, indicates that 22% of adults will change risk categories under the new PREVENT-atherosclerotic cardiovascular disease … Read more
New research led by Niigata University indicates that the risk of Alzheimer’s disease associated with carrying two copies of the APOE4 gene variant is lower in Japanese populations than previously estimated. A meta-analysis published in the journal Molecular Neurodegeneration suggests that Japanese APOE4 homozygotes face a 12–15-fold increased risk of developing the disease, lower than … Read more
Women diagnosed with Parkinson’s disease exhibit a higher amyloid plaque burden in the brain compared to men, according to a study led by the Mayo Clinic Arizona. While men with Parkinson’s are generally at a higher risk of developing dementia, this new research indicates that women harbor more Alzheimer’s-related protein deposits, even when adjusting for … Read more
Researchers at Radboud University Medical Center have developed a long-read genome sequencing test capable of replacing 15 standard genetic diagnostics with a single analysis. According to a study published in the New England Journal of Medicine, this technology identifies complex mutations and epigenetic modifications that conventional short-read sequencing often misses, potentially accelerating diagnosis for the … Read more
Unlocking the Genetic Blueprint: The Future of Alzheimer’s Prevention For decades, the search for an Alzheimer’s “cure” has felt like navigating a labyrinth in the dark. While the APOE ε4 gene has long been our primary beacon, a massive, unprecedented genetic study has finally turned on the lights. By analyzing nearly one million individuals, researchers … Read more
The Future of Alzheimer’s: Shifting from Late-Stage Reaction to Early Detection For decades, Alzheimer’s disease has been characterized as a diagnosis that arrives only after major symptoms manifest. However, the medical landscape is undergoing a paradigm shift. With new research published in The Lancet, the focus is moving toward detecting the disease years—or even decades—before … Read more